SEC Form 4Coverage since Jun 15, 2026
$IMRX insider trading
Over the last 12 months, Immuneering insiders reported 2 buys totaling $36K and no sales across SEC Form 4 filings.
- Bought · 12m
- $36K 2 events
- Sold · 12m
- — 0 events
- Events · 12m
- 2 Form 4 filings, grouped
- Insiders · 12m
- 2 distinct reporters
- 10b5-1 share
- 0% pre-arranged plans
Side
Price · $IMRX · 12Mvia TradingView
Top insiders · 12m
Hall Brett MatthewCHIEF SCIENTIFIC OFFICER1× · $25K
Zeskind Benjamin J.PRESIDENT AND CEO1× · $11K
All insider trades
2 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jun 23, 2026 | Zeskind Benjamin J.PRESIDENT AND CEO · O·D | ▲ Buy | 2,400 | $4.56 | $11K | +0.1% | — |
| Jun 15, 2026 | Hall Brett MatthewCHIEF SCIENTIFIC OFFICER · O | ▲ Buy | 6,035 | $4.15 | $25K | +1.6% | — |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $IMRX feed.